SG10202010758SA - Method of predicting breast cancer prognosis - Google Patents
Method of predicting breast cancer prognosisInfo
- Publication number
- SG10202010758SA SG10202010758SA SG10202010758SA SG10202010758SA SG10202010758SA SG 10202010758S A SG10202010758S A SG 10202010758SA SG 10202010758S A SG10202010758S A SG 10202010758SA SG 10202010758S A SG10202010758S A SG 10202010758SA SG 10202010758S A SG10202010758S A SG 10202010758SA
- Authority
- SG
- Singapore
- Prior art keywords
- breast cancer
- cancer prognosis
- predicting breast
- predicting
- prognosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161557238P | 2011-11-08 | 2011-11-08 | |
| US201261597426P | 2012-02-10 | 2012-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202010758SA true SG10202010758SA (en) | 2020-11-27 |
Family
ID=48290467
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202010758SA SG10202010758SA (en) | 2011-11-08 | 2012-11-02 | Method of predicting breast cancer prognosis |
| SG11201402042PA SG11201402042PA (en) | 2011-11-08 | 2012-11-02 | Method of predicting breast cancer prognosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402042PA SG11201402042PA (en) | 2011-11-08 | 2012-11-02 | Method of predicting breast cancer prognosis |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20140296085A1 (https=) |
| EP (1) | EP2776830B1 (https=) |
| JP (2) | JP6147755B2 (https=) |
| AU (1) | AU2012336120B2 (https=) |
| CA (1) | CA2854805C (https=) |
| IL (4) | IL232445B (https=) |
| MX (1) | MX357402B (https=) |
| SG (2) | SG10202010758SA (https=) |
| WO (1) | WO2013070521A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| US9856533B2 (en) | 2003-09-19 | 2018-01-02 | Biotheranostics, Inc. | Predicting breast cancer treatment outcome |
| CN103998064A (zh) | 2010-12-09 | 2014-08-20 | 生物诊断治疗公司 | 治疗后的乳腺癌预后 |
| WO2014044724A1 (en) * | 2012-09-18 | 2014-03-27 | Qiagen Gmbh | Method and kit for preparing a target rna depleted sample |
| US10487362B2 (en) * | 2013-01-09 | 2019-11-26 | Health Research, Inc. | Methods for diagnosing cancer based on small nucleolar RNA HBII-52 |
| WO2014130444A1 (en) * | 2013-02-19 | 2014-08-28 | Genomic Health, Inc. | Method of predicting breast cancer prognosis |
| BR112016005225B1 (pt) * | 2013-09-11 | 2023-11-14 | Bio Theranostics, Inc | Métodos para avaliar câncer de mama em um indivíduo |
| US20160259881A1 (en) * | 2013-10-29 | 2016-09-08 | Genomic Health, Inc. | Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence risk |
| CN105214077B (zh) * | 2014-06-03 | 2019-02-05 | 浙江阿思科力生物科技有限公司 | Usp33在肿瘤中的应用 |
| WO2016094330A2 (en) * | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
| JP6932080B2 (ja) * | 2014-12-10 | 2021-09-08 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 非コード−コード遺伝子共発現ネットワークを生成する方法及びシステム |
| JP6876680B2 (ja) | 2015-09-01 | 2021-05-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ネオモルフィックｓｆ３ｂ１変異体に関連するスプライスバリアント |
| EP3365000B1 (en) | 2015-10-23 | 2020-06-10 | Novartis AG | Method of deriving a value for percent biomarker positivity for selected cells present in a field of view |
| WO2017083675A1 (en) | 2015-11-13 | 2017-05-18 | Biotheranostics, Inc. | Integration of tumor characteristics with breast cancer index |
| EP3202913B1 (en) * | 2016-02-08 | 2019-01-30 | King Faisal Specialist Hospital And Research Centre | A set of genes for use in a method of predicting the likelihood of a breast cancer patient's survival |
| CA3063450A1 (en) * | 2017-05-19 | 2018-11-22 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| US20190376115A1 (en) * | 2018-06-08 | 2019-12-12 | Glympse Bio, Inc. | Activity sensor design |
| CN108893537B (zh) * | 2018-07-19 | 2020-10-30 | 青岛泱深生物医药有限公司 | C7orf70及其应用 |
| JP2020028278A (ja) * | 2018-08-24 | 2020-02-27 | 国立大学法人九州大学 | 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法 |
| CN113748215B (zh) * | 2018-11-04 | 2024-07-23 | Pfs基因组学公司 | 用于乳腺癌的预后和预测来自辅助放射疗法的益处的方法和基因组分类器 |
| CN109859801B (zh) * | 2019-02-14 | 2023-09-19 | 辽宁省肿瘤医院 | 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法 |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US20240218448A1 (en) * | 2020-04-23 | 2024-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions related to full-length excised intron rnas (flexi rnas) |
| JP2023542867A (ja) | 2020-09-11 | 2023-10-12 | グリンプス バイオ， インコーポレイテッド | 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出 |
| RU2763839C1 (ru) * | 2021-04-27 | 2022-01-11 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Петрова" Минздрава России) | Способ многофакторного прогноза рака молочной железы |
| CN113667749A (zh) * | 2021-08-03 | 2021-11-19 | 广东省人民医院 | 四个关键基因组合评估乳腺癌风险的诊断试剂盒 |
| CN114480650A (zh) * | 2022-02-08 | 2022-05-13 | 深圳市陆为生物技术有限公司 | 一种预测三阴乳腺癌临床预后复发风险的标志物及模型 |
| CN114657242B (zh) * | 2022-03-16 | 2022-11-11 | 广州医科大学附属第一医院 | Gpr33基因在马尔尼菲篮状菌易感人群评估的应用 |
| CN121137157B (zh) * | 2025-11-17 | 2026-02-10 | 长春科技学院 | 一种评估上皮性卵巢癌复发风险的试剂的用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2374311T3 (es) * | 2002-03-13 | 2012-02-15 | Genomic Health, Inc. | Obtención de perfil de expresión génica en tejidos tumorales biopsiados. |
| US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| WO2005001138A2 (en) * | 2003-06-18 | 2005-01-06 | Arcturus Bioscience, Inc. | Breast cancer survival and recurrence |
| AU2004258085B2 (en) * | 2003-07-10 | 2010-05-27 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| JP2005270093A (ja) * | 2004-02-24 | 2005-10-06 | Nippon Medical School | 乳癌の術後予後予測に関与する遺伝子 |
| EP1797429A2 (en) * | 2004-09-30 | 2007-06-20 | Bayer HealthCare AG | Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy |
| EP2061885A4 (en) * | 2006-09-15 | 2011-03-09 | Univ Mcgill | STROMA-DERIVED PREDICTOR FOR BREAST CANCER |
| WO2008079269A2 (en) * | 2006-12-19 | 2008-07-03 | Genego, Inc. | Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom |
| EP2036988A1 (en) * | 2007-09-12 | 2009-03-18 | Siemens Healthcare Diagnostics GmbH | A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| WO2009071655A2 (en) * | 2007-12-06 | 2009-06-11 | Siemens Healthcare Diagnostics Inc. | Methods for breast cancer prognosis |
| US20110020370A1 (en) * | 2008-12-11 | 2011-01-27 | Elias Georges | Slc7a5 directed diagnostics and therapeutics for neoplastic disease |
| CN101851611A (zh) * | 2009-04-01 | 2010-10-06 | 天津医科大学附属肿瘤医院 | 驱动蛋白样蛋白kif1b的转移相关功能和预测肿瘤患者预后的标志物用途及其应用方法 |
| WO2010127399A1 (en) * | 2009-05-06 | 2010-11-11 | Walter And Eliza Hall Institute Of Medical Research | Gene expression profiles and uses thereof |
| US20120309640A1 (en) * | 2009-10-08 | 2012-12-06 | Torti Frank M | Diagnostic and Prognostic Markers for Cancer |
| MX337650B (es) * | 2009-11-23 | 2016-03-14 | Genomic Health Inc | Metodos para predecir el desenlace clinico del cancer. |
| WO2011068839A1 (en) * | 2009-12-01 | 2011-06-09 | Compendia Bioscience, Inc. | Classification of cancers |
| GB0922437D0 (en) * | 2009-12-22 | 2010-02-03 | Cancer Rec Tech Ltd | Hypoxia tumour markers |
| US20130143753A1 (en) * | 2010-03-01 | 2013-06-06 | Adelbio | Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom |
| EP2845911B1 (en) * | 2010-03-31 | 2016-05-18 | Sividon Diagnostics GmbH | Method for breast cancer recurrence prediction under endocrine treatment |
-
2012
- 2012-11-02 SG SG10202010758SA patent/SG10202010758SA/en unknown
- 2012-11-02 SG SG11201402042PA patent/SG11201402042PA/en unknown
- 2012-11-02 WO PCT/US2012/063313 patent/WO2013070521A1/en not_active Ceased
- 2012-11-02 JP JP2014540131A patent/JP6147755B2/ja active Active
- 2012-11-02 AU AU2012336120A patent/AU2012336120B2/en active Active
- 2012-11-02 CA CA2854805A patent/CA2854805C/en active Active
- 2012-11-02 MX MX2014005547A patent/MX357402B/es active IP Right Grant
- 2012-11-02 US US14/355,642 patent/US20140296085A1/en not_active Abandoned
- 2012-11-02 EP EP12847964.9A patent/EP2776830B1/en active Active
-
2014
- 2014-05-04 IL IL232445A patent/IL232445B/en active IP Right Grant
-
2016
- 2016-01-29 US US15/011,206 patent/US20160222463A1/en not_active Abandoned
- 2016-12-27 JP JP2016252390A patent/JP2017055769A/ja active Pending
-
2018
- 2018-09-12 IL IL261708A patent/IL261708A/en unknown
-
2019
- 2019-01-17 US US16/250,179 patent/US20190256923A1/en not_active Abandoned
- 2019-03-03 IL IL265136A patent/IL265136B/en active IP Right Grant
-
2020
- 2020-02-07 US US16/784,696 patent/US20200263257A1/en not_active Abandoned
- 2020-08-04 IL IL276488A patent/IL276488B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20190256923A1 (en) | 2019-08-22 |
| IL261708A (en) | 2018-10-31 |
| SG11201402042PA (en) | 2014-06-27 |
| CA2854805A1 (en) | 2013-05-16 |
| IL265136B (en) | 2020-08-31 |
| AU2012336120A1 (en) | 2014-05-29 |
| IL232445B (en) | 2018-10-31 |
| WO2013070521A1 (en) | 2013-05-16 |
| NZ624700A (en) | 2016-08-26 |
| IL276488B (en) | 2021-04-29 |
| IL232445A0 (en) | 2014-06-30 |
| JP6147755B2 (ja) | 2017-06-14 |
| JP2017055769A (ja) | 2017-03-23 |
| MX2014005547A (es) | 2014-08-29 |
| EP2776830A4 (en) | 2015-07-15 |
| US20160222463A1 (en) | 2016-08-04 |
| JP2014532428A (ja) | 2014-12-08 |
| CA2854805C (en) | 2021-04-27 |
| US20200263257A1 (en) | 2020-08-20 |
| MX357402B (es) | 2018-07-09 |
| EP2776830B1 (en) | 2018-05-09 |
| EP2776830A1 (en) | 2014-09-17 |
| AU2012336120B2 (en) | 2017-10-26 |
| US20140296085A1 (en) | 2014-10-02 |
| IL276488A (en) | 2020-09-30 |
| HK1201329A1 (en) | 2015-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276488B (en) | A method for predicting breast cancer prognosis | |
| GB201102014D0 (en) | Method for predicting risk of developing cancer | |
| IL251403B (en) | A method for using gene expression to determine the prognosis of prostate gland cancer | |
| SG10201704311VA (en) | Methods for predicting risk of developing hypertension | |
| PL2714926T3 (pl) | Biomarkery raka płuca | |
| PL2741085T3 (pl) | Sposób wykrywania raka trzustki | |
| SG10201703022SA (en) | Method of prognosis and stratification of ovarian cancer | |
| GB2513275B (en) | Biomarkers for Breast Cancer Prediction and Diagnosis | |
| ZA201205003B (en) | Methods for treating breast cancer | |
| EP2721180A4 (en) | GENETIC VARIANTS FOR PREDICTING THE RISK OF BREAST CANCER | |
| IL237436A0 (en) | A method for screening cancer | |
| PH12013501570A1 (en) | Improved method of ore processing | |
| EP2668295A4 (en) | METHODS OF DETECTING LUNG CANCER | |
| IL232493A0 (en) | A method for quantifying cancer treatment | |
| SG10201507582VA (en) | Biomarkers for predicting sensitivity to cancer treatments | |
| SG11201402115TA (en) | Methods for diagnosis and/or prognosis of gynecological cancer | |
| GB2510539B (en) | Biomarkers of cancer | |
| IL214476A0 (en) | Method for predicting breast and ovarian cancer risk | |
| GB201107118D0 (en) | Method of diagnosis and prognosis | |
| EP3060914A4 (en) | Methods of determining breast cancer prognosis | |
| GB201104205D0 (en) | F56 biomarkers for prostate cancer | |
| GB201118778D0 (en) | Biomarker method | |
| IL229109A0 (en) | Cancer diagnosis | |
| AU2011901456A0 (en) | Method of diagnosing cancer | |
| GB201002366D0 (en) | Cancer prognosis |